US FDA approves Roche’s cobas SARS-CoV-2 Qualitative PCR test
The cobas SARS-CoV-2 Qualitative assay is a single-well dual target assay that enables both specific detection of SARS-CoV-2…
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
25 Oct 22
The cobas SARS-CoV-2 Qualitative assay is a single-well dual target assay that enables both specific detection of SARS-CoV-2…
25 Oct 22
Both firms will co-promote FibroScan and LIVErHEALTHY as the preferred non-invasive testing and digital therapeutic platform, respectively, for…
25 Oct 22
The Dutch health technology company has been hit with a loss of €1.5bn in Q3 2022, which was…
25 Oct 22
The RELIEVE-HF trial of the Ventura Shunt System includes patients with reduced and preserved left ventricular function etiologies…
25 Oct 22
With a starter pack priced at $10,455, the PromethION 2 Solo device becomes the most accessible, high yield…
25 Oct 22
The Revolution Circulating Free Total Nucleic Acid (cfTNA) Kit™ and cfDNA Reference Standard products are designed to advance…
24 Oct 22
With the addition of the FDA-approved and CE-marked AI algorithm, aiOS can deliver a completely automated and standardised…
21 Oct 22
The company announced the FDA approval for its AI-enabled MR for Calculating Attenuation (MRCAT) Head and Neck radiotherapy…
21 Oct 22
Intelligent Ultrasound intends to commercialise the AI-based medical device in the US anaesthesiology ultrasound market, as a stand-alone…
21 Oct 22
The TELIGEN System is said to be an integrated technology platform which uses digital tools for visualisation and…